Diagnamed Holdings (XCNQ:DMED) ROCE % : -242.66% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Diagnamed Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Diagnamed Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was -242.66%.

Diagnamed Holdings ROCE % Historical Data

The historical data trend for Diagnamed Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnamed Holdings ROCE % Chart

Diagnamed Holdings Annual Data

Trend

Sep21

Sep22

Sep23

ROCE %

-30.54

-65.17

-169.10

Diagnamed Holdings Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial					-131.43	-234.71	-156.47	-260.41	-242.66

Diagnamed Holdings ROCE % Calculation

Diagnamed Holdings's annualized ROCE % for the fiscal year that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	-1.253	/	( ( (1.616 - 0.37)	+	(0.662 - 0.426) )	/ 2 )
	=	-1.253	/	( (1.246	+	0.236)	/ 2 )
	=	-1.253	/	0.741
	=	-169.10 %

Diagnamed Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-0.62	/	( ( (0.662 - 0.426)	+	(0.55 - 0.275) )	/ 2 )
	=	-0.62	/	( ( 0.236	+	0.275 )	/ 2 )
	=	-0.62	/	0.2555
	=	-242.66 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Diagnamed Holdings (XCNQ:DMED) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Diagnamed Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Diagnamed Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnamed Holdings (XCNQ:DMED) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnamed Holdings Corp (XCNQ:DMED) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

DGNMF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.diagnamed.com

Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its product includes BrainYear and BrainTremor.

Executives

Fabio Chianelli

Director, Senior Officer

Diagnamed Holdings (XCNQ:DMED) Headlines

No Headlines